Business

Motilal Oswal Alternates Commits $72 Million to Boost Hyderabad-Based Medtech Firm Sensa Core

The fresh capital infusion will be channelled towards accelerating product innovation, expanding manufacturing capacity and scaling the firm’s international footprint. Sensa Core is already advancing its facilities in the Hyderabad Export Promotion Industrial Park and is commissioning a new production unit at the Medical Device Park in Sultanpur, Telangana to support future growth.

• By Newsdesk
• Mumbai
• Dec 23, 2025

Business

In a major push for India’s medical technology sector, Motilal Oswal Alternates has announced a $72 million investment in Sensa Core Medical Instrumentation, securing a significant minority stake in the Hyderabad-based diagnostic devices company. The deal, unveiled on Monday, marks one of the most substantial private capital commitments this year in the domestic medtech space. 

Founded in 2006, Sensa Core has emerged as a leading homegrown manufacturer of in-vitro diagnostic (IVD) equipment, with its products—including electrolyte analysers, glucometers and haemoglobin meters—installed in more than 40,000 hospitals and diagnostic laboratories across India. The company also exports its devices to over 78 countries, reflecting its global reach and ambition. 

The fresh capital infusion will be channelled towards accelerating product innovation, expanding manufacturing capacity and scaling the firm’s international footprint. Sensa Core is already advancing its facilities in the Hyderabad Export Promotion Industrial Park and is commissioning a new production unit at the Medical Device Park in Sultanpur, Telangana to support future growth.

In a statement, Rohit Mantri, Managing Director and Co-Head of Private Equity at Motilal Oswal Alternates, said the investment underscores confidence in India’s burgeoning medical devices ecosystem and aligns with efforts to reduce the country’s reliance on imported healthcare technology. India currently imports more than 75% of its medical devices, a gap industry leaders say presents vast opportunities for domestic innovators. 

Dr Ravi Kumar Meruva, Founder and Managing Director of Sensa Core, welcomed the partnership, noting that the capital will support deeper automation, enhanced quality assurance and the development of next-generation diagnostic solutions. He emphasised that the company’s journey from a bootstrapped startup to a global exporter reflects the rising competitiveness of indigenous medtech manufacturing.

With this strategic backing, Sensa Core is positioned to strengthen its leadership in critical diagnostic segments while contributing to broader efforts to make advanced healthcare technologies affordable and widely accessible both within India and abroad.